Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
BrightGene Presents Positive Phase 2 Data for Dual GLP-1R/GIPR Agonist for Weight Management and Type 2 Diabetes and Preclinical Data for Novel Amylin Analog at American Diabetes Association's 85th Scientific Sessions 2025-06-24 08:54
1